Pharmaceutical firm definition

Pharmaceutical firm means a business engaged in the dis- pensing, delivering, distributing, manufacturing, or wholesaling of prescription drugs or devices within or into Washington state.
Sample 1Sample 2Sample 3

Examples of Pharmaceutical firm in a sentence

  • For the drugs quoted in the tender enquiry, Participating Pharmaceutical firm will have to submit the samples on demand.

  • In case of narcotics, the Participating Pharmaceutical firm will have to submit the narcotic drug license issued by the licensing authorities.

  • For the drugs which are being imported, the Participating Pharmaceutical firm will submit valid import license issued by Drug Controller General of India and valid marketing license issued by concerned Licensing Authority (Form 10 & Form 41).

  • In case of newly introduced drugs, the Participating Pharmaceutical firm will submit valid certificate from the Drug Controller General of India in support of the claim and valid Drug license from the Licensing Authority.

  • The Participating Pharmaceutical firm shall also submit the requisite documents regarding particular drug(s) being under Patent and the date of end of Patent from Patent Office.

  • Participating Pharmaceutical firm must have a valid GMP/ WHO-GMP certificate for the quoted drug(s) / manufacturing unit..

  • The Participating Pharmaceutical firm must have in house testing facilities and valid Good Laboratory Practice (GLP Certificate) as per schedule „L1‟ of the Drugs & Cosmetics Rules issued by Central / State Drug Controller / FDA for the quoted drugs (as applicable).

  • Objectives On completion of this course it is expected that students will be able to understand- • The scheduled activities in a Pharmaceutical firm.

  • Participating Pharmaceutical firm should submit a non-conviction certificate issued by the State Drug Controller, to the effect that the manufacturer has not been convicted under the Drugs and Cosmetics Act, 1940 and rules there under, for any of the quoted drugs.

  • Pharmaceutical firm having minimum annual turnover of Rs. 50/- Crore in each of the last two years will be eligible to quote bid for drugs included in Group ‘ B’(The Group B drugs-includes rest of the drugs not covered under Group A).

Related to Pharmaceutical firm

  • Pharmaceutical Product shall have the meaning ascribed to such term in Section 3.1(hh).

  • Radiopharmaceutical means any drug that exhibits spontaneous disintegration of unstable nuclei with the emission of nuclear particles or photons and includes any non-radioactive reagent kit or radionuclide generator that is intended to be used in the preparation of any such substance, but does not include drugs such as carbon-containing compounds or potassium-containing salts that include trace quantities of naturally occurring radionuclides. The term also includes any biological product that is labeled with a radionuclide or intended solely to be labeled with a radionuclide.

  • Pharmaceutical care means the provision of drug therapy and

  • Radiopharmaceutical quality assurance means, but is not limited to, the performance of appropriate chemical, biological, and physical tests on potential radiopharmaceuticals and the interpretation of the resulting data to determine their suitability for use in humans and animals, including internal test assessment, authentication of product history, and the keeping of proper records.

  • Radiopharmaceutical service means, but is not limited to, the procurement, storage, handling preparation, labeling, quality assurance testing, dispensing, delivery, recordkeeping, and disposal of radiopharmaceuticals and other drugs.

  • Therapeutic school means a residential group living facility:

  • Biotechnology means any technological application that uses biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use.

  • Competing Product means [***].

  • Biological product means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein other than a chemically synthesized polypeptide, or analogous product, or arsphenamine or any derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human beings.

  • Clinical experience means providing direct services to individuals with mental illness or the provision of direct geriatric services or special education services. Experience may include supervised internships, practicums, and field experience.

  • Competing Products means any product or service in existence or under development that competes with any product or service of the Company Group about which the Participant obtained Confidential Information or for which the Participant provided advisory services or had sales, origination, marketing, production, distribution, research or development responsibilities in the last twenty-four (24) months of employment with the Company Group.

  • Biosimilar Product means, with respect to a Licensed Product in any country, any biosimilar product sold by a Third Party not authorized by or on behalf of Celgene, its Affiliates or Sublicensees, (a) that is a biosimilar biological product, as defined in 21 USC 379j-51 (or any successor or replacement thereof), a similar biological medicinal product, as defined in Annex I to Directive 2001/83/EC (or any successor or replacement thereof), or any similar biosimilar or generic product under the Laws of any country or jurisdiction, or (b) regarding which Regulatory Approval is obtained by referencing Regulatory Data of such Licensed Product.

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.

  • veterinary surgeon means a veterinary surgeon within the meaning of the Veterinary Surgeons Act 1936.

  • Reference biological product means the single biological product licensed pursuant to 42 U.S.C.